Can You Stop Wegovy Abruptly — or Does It Need to Be Tapered?

Wegovy (semaglutide) has a long half-life of about a week, so its effects fade gradually over several weeks after your last injection — there is no acute withdrawal syndrome.
Most clinical trial data show meaningful weight regain begins within weeks of stopping, with around two-thirds of lost weight returning within a year for many people.
Appetite, hunger hormones and gastric-emptying rate tend to revert towards pre-treatment levels once semaglutide clears your system.
Stopping temporarily (for surgery, pregnancy planning or supply reasons) has different considerations from stopping permanently; a prescriber should guide each scenario.

Stopping Wegovy abruptly is not dangerous in the way suddenly stopping some medicines is, but it is almost always a poor strategy. There is no medically necessary taper, yet most people who stop without a plan see their appetite return quickly and regain a significant portion of lost weight within months. Wegovy is a prescription-only medicine; any decision to stop, pause or reduce your dose should be discussed with the prescriber who manages your treatment, because the right approach depends on your individual circumstances.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What stopping Wegovy actually does to your body, and when pausing makes clinical sense

The misconception: that you can simply stop when you hit your target weight

The most common misunderstanding about Wegovy is that it works like a course of antibiotics, you take it, you reach your goal, you stop, and the result sticks. That framing is wrong, and it leads a lot of people into frustrating cycles of stopping and restarting.

Wegovy works by activating GLP-1 receptors that regulate appetite, gastric emptying and the hormonal signals that tell your brain you have eaten enough. Those mechanisms are active only while semaglutide is present in your system. The medicine does not permanently reset your biology. Once it clears, typically over three to four weeks given its roughly seven-day half-life, the hunger signals that were quietened gradually return to their pre-treatment pattern.

The STEP 1 trial, published in the New England Journal of Medicine, followed participants after they stopped semaglutide and found that body weight and cardiometabolic risk markers largely returned towards baseline within a year of stopping. That does not make Wegovy ineffective, it makes it a long-term treatment for a long-term condition, in the same way blood-pressure medication stops working when you stop taking it. Understanding this changes how people should approach the question of stopping.

If you are weighing up whether to continue, read about what happens if you take Wegovy and then stop for a fuller picture of the research.

What abruptly stopping actually feels like, the physiology, not a scare story

Because semaglutide has a long half-life, stopping your weekly injection is not like switching off a light. The drop-off is gradual. During the first two weeks after your last dose, most people notice little change. By weeks three and four, appetite typically starts to increase. By week six or eight, hunger may feel similar to how it did before treatment began.

There is no withdrawal syndrome in the clinical sense, no shaking, no rebound anxiety, no dependence response. What people describe is the return of appetite, sometimes with extra intensity in the early weeks, and a return of food noise (the persistent background preoccupation with eating that many people had before treatment). Gastric emptying speeds back up, which means meals feel less filling.

For some people this is manageable. For others, especially those who relied heavily on the appetite-suppression effect rather than building new habits alongside treatment, it can feel abrupt even when the pharmacology is gradual. If you are wondering whether Wegovy can be stopped abruptly and what the physiology actually involves, that page sets out the detail clearly. The NHS semaglutide information page describes the medicine's mechanism and what to expect, and is worth reading before making any changes.

Practically, if your pen lives in the fridge door and you have just not ordered your next supply, that is not a planned stop, it is a gap. Gaps carry the same rebound risk as deliberate stopping, so it is worth thinking about supply continuity as part of your treatment plan.

When stopping or pausing is clinically justified, and how to approach it

There are legitimate reasons to stop Wegovy: planned surgery, pregnancy or trying to conceive, a new clinical assessment that changes your treatment, or a decision made jointly with your prescriber that you have reached a stable maintenance point and want to trial life without the medicine. None of these scenarios require you to taper the dose, there is no dose-reduction schedule equivalent to what you would follow stopping a corticosteroid, for example.

What they do require is a conversation with the prescriber managing your treatment. For surgery specifically, NHS England advises informing your anaesthetist and surgical team that you are on a GLP-1 medicine, because of effects on gastric emptying and aspiration risk under anaesthetic. For pregnancy planning, guidance recommends stopping semaglutide and using effective contraception during the wash-out period before trying to conceive, your prescriber will advise on timing. Many patients also find it helpful to read a dedicated guide on whether you can stop using Wegovy, which covers the key considerations across different circumstances, including temporary pauses. You can also read more about starting and stopping Wegovy in different circumstances, including temporary pauses.

If you are stopping because of side effects rather than a planned decision, that is especially worth discussing before acting, many side-effect issues are manageable with dose adjustments, timing changes or short-term strategies, and your prescriber may have options you have not tried. For general questions about the medicine, our Wegovy overview covers the full picture.

Practical options if you are considering stopping, including what to think about first

Before stopping, it helps to distinguish between three different situations: wanting to stop permanently because treatment is complete; wanting to pause temporarily; and wanting to stop because something is not working. Each calls for a different response.

For a permanent stop, the most useful question is whether the lifestyle patterns built during treatment (eating habits, activity levels, relationship with hunger) are solid enough to support weight maintenance without pharmacological help. Many people benefit from a structured plan with a dietitian or a weight-management programme running alongside or after treatment. The NHS does not currently fund Wegovy for ongoing private use, and NICE's guidance under TA875 recommends a maximum two-year treatment period within specialist services for NHS-commissioned patients, partly because of this long-term dependency question.

For a temporary pause, supply interruptions or short medical holds are common. Restarting after a break of more than a few weeks may mean returning to a lower dose to re-establish tolerability, which is a decision for your prescriber rather than something to self-manage.

If you are at the stage of thinking about where to get ongoing treatment or assessment, guidance on accessing Wegovy through a regulated UK pharmacy may be useful. And if you want to explore your broader options, our weight-loss treatment overview sets out what is available and how each route works.

If you are unsure which path makes sense for you, a clinical review is the clearest next step. Our prescribers at nume review consultations the same day, a real clinician reads your details, not software. Start your free consultation to talk through your situation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions